IMA Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.94K	Sell	52 -2	-4%	-$117	﹤0.01%	540
2025 Q4	$3.21K	Buy	+54	New	+$2.94K	﹤0.01%	535
2022 Q1	–	Sell	-1,500	Closed	-$133K	–	300
2021 Q4	$133K	Sell	1,500 -32,048	-96%	-$2.64M	0.03%	143
2021 Q3	$2.59M	Buy	33,548 +1,092	+3%	+$86.2K	0.61%	57
2021 Q2	$2.71M	Sell	32,456 -426	-1%	-$33.8K	0.63%	57
2021 Q1	$2.48M	Buy	32,882 +7,350	+29%	+$600K	0.61%	65
2020 Q4	$2.24M	Sell	25,532 -8,553	-25%	-$678K	0.63%	58
2020 Q3	$2.59M	Buy	34,085 +5,151	+18%	+$521K	0.87%	36
2020 Q2	$3.57M	Sell	28,934 -10,298	-26%	-$1.02M	1.29%	22
2020 Q1	$3.31M	Sell	39,232 -2,008	-5%	-$173K	1.46%	17
2019 Q4	$3.49M	Buy	41,240 +521	+1%	+$39.4K	1.29%	22
2019 Q3	$2.74M	Buy	40,719 +3,353	+9%	+$258K	1.04%	35
2019 Q2	$3.2M	Sell	37,366 -2,293	-6%	-$196K	1.2%	29
2019 Q1	$3.52M	Buy	39,659 +704	+2%	+$65.2K	1.37%	21
2018 Q4	$3.32M	Buy	38,955 +941	+2%	+$89.5K	1.55%	15
2018 Q3	$3.69M	Buy	38,014 +2,876	+8%	+$287K	1.44%	18
2018 Q2	$3.31M	Buy	35,138 +417	+1%	+$36.5K	1.38%	19
2018 Q1	$2.81M	Buy	+34,721	New	+$2.98M	1.25%	24